SCHEMBL15037813

SCHEMBL15037813

CCC1=CC=C(I)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9028897 0.84 NOS3 (0.37)
SCHEMBL26458737 0.77 NOS3 (0.31)
SCHEMBL14234595 0.75
SCHEMBL22642160 0.74 NOS3 (0.37)
SCHEMBL2534579 0.72
SCHEMBL19266629 0.72 NOS3 (0.31)
SCHEMBL12345407 0.70
SCHEMBL19141600 0.70
SCHEMBL14291473 0.69
SCHEMBL22019059 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11545354-B2 Molecular layer deposition method and system APPLIED MATERIALS, INC. (US) 2023-01-03 US disclosed
US-20220028686-A1 MOLECULAR LAYER DEPOSITION METHOD AND SYSTEM APPLIED MATERIALS, INC. (US) 2022-01-27 US disclosed
WO-2017060771-A2 COMBINATION THERAPIES FOR TREATING CANCER REDHILL BIOPHARMA LTD. (IL) 2017-04-13 WO disclosed
EP-2604269-A1 1,4-benzodiazepine-2,5-diones with therapeutic properties THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2013-06-19 EP disclosed